Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Impact of metabolic dysfunction associated fatty liver disease on the prognosis of patients with hepatitis B virus-related hepatocellular carcinoma based on propensity …
J Xue, QX Wang, HM **ao, MJ Shi, YB **e… - Cancer Management …, 2023 - Taylor & Francis
Purpose Both metabolic dysfunction-associated fatty liver disease (MAFLD) and hepatitis B
virus (HBV) are risk factors for hepatocellular carcinoma (HCC). Although concurrent MAFLD …
virus (HBV) are risk factors for hepatocellular carcinoma (HCC). Although concurrent MAFLD …
Serum Level of Tumor-Specific Growth Factor in Patients with Cervical Cancer and Its Potential Prognostic Role.
Y Wu, B Qu, H Shen, H Deng… - Oncologie (Tech Science …, 2022 - search.ebscohost.com
Background: Tumor-specific growth factor (TSGF) is associated with invasion and metastasis
of various malignancies and adverse clinical outcomes. TSGF is also highly expressed in …
of various malignancies and adverse clinical outcomes. TSGF is also highly expressed in …
Response Assessment of Primary Liver Tumors to Novel Therapies: an Imaging Perspective
The latest developments in cancer immunotherapy, namely the introduction of immune
checkpoint inhibitors, have led to a fundamental change in advanced cancer treatments …
checkpoint inhibitors, have led to a fundamental change in advanced cancer treatments …
A predictive nomogram for atypical meningioma based on preoperative magnetic resonance imaging and routine blood tests
Y Lin, P Dai, Q Lin, J Chen - World Neurosurgery, 2022 - Elsevier
Objective The objective of the study was to establish a 5-year progression-free survival
prediction nomogram using preoperative routine blood tests and magnetic resonance …
prediction nomogram using preoperative routine blood tests and magnetic resonance …
The combination of a prolonged treatment time window and alpha-fetoprotein benefits the tumor response of hepatocellular carcinoma patients as evaluated by the …
KL Yin, M Li, R Liao, ZR Shi, JG Qiu… - Journal of …, 2023 - pmc.ncbi.nlm.nih.gov
Background The combined immunotargeting therapy of hepatocellular carcinoma (HCC)
have brought remarkable results. There are still some drawbacks to the application of the …
have brought remarkable results. There are still some drawbacks to the application of the …
The Additive Value of Radiomics Features Extracted from Baseline MR Images to the Barcelona Clinic Liver Cancer (BCLC) Staging System in Predicting Transplant …
Background: To study the additive value of radiomics features to the BCLC staging system in
clustering HCC patients. Methods: A total of 266 patients with HCC were included in this …
clustering HCC patients. Methods: A total of 266 patients with HCC were included in this …
Apatinib plus drug-eluting bead transarterial chemoembolization as bridging therapy to surgical resection displays an acceptable efficacy and safety profile in …
J Yan, Y Sun, D Fan, W Mu - Indian Journal of Cancer, 2023 - journals.lww.com
Background: Apatinib exhibits a synergistic effect with transarterial chemoembolization
(TACE) by inhibiting TACE-induced neoangiogenic reaction in hepatocellular carcinoma …
(TACE) by inhibiting TACE-induced neoangiogenic reaction in hepatocellular carcinoma …
[PDF][PDF] Lymphocytopenia is a main sensitive risk factor of primary liver cancer complicated with bacterial infections
W Ye, H Zhao, Y Guo - 2024 - assets-eu.researchsquare.com
As we known immunity and in ammation play an important role in primary liver cancer (PLC)
development. Through retrospective analysis of patients with or with PLC in our center in …
development. Through retrospective analysis of patients with or with PLC in our center in …
Magnetic Resonance Imaging Predictors of Hepatocellular Carcinoma Progression and Dropout in Patients in Liver Transplantation Waiting List
Background. With the rising incidence of hepatocellular carcinoma (HCC), more patients are
now eligible for liver transplantation. Consequently, HCC progression and dropout from the …
now eligible for liver transplantation. Consequently, HCC progression and dropout from the …